Syphilis is a disease caused by Treponema pallidum. It is primarily transmitted sexually or vertically during pregnancy. The origin is twofold, namely, it comes from America or Europe. Syphilis was first recorded in a human skeleton in the 11th century. However, signs of treponemal disease were observed in osteological material from a Pleistocene bear. Hence, it is necessary to study syphilis on bone material to better understand the etiology of the above disease and, consequently, introduce preventive measures. Examination of syphilis on skeletal material can be performed at the macroscopic and microscopic levels. Those methods refer to the visual assessment of skeletal material, namely the identification of characteristic pathological changes caused by syphilis, such as periostitis, which manifests itself as thickenings on the bone surface, and syphilis nodules (gummata), which are defects in the bones. Most often, these changes are found on long bones such as the tibia, femur, and skull. Radiological methods may be used, such as X-ray, computed tomography (CT), Micro-CT (ICT), as well as molecular examination. Summarizing, this review is an overview of the latest methodology regarding syphilis research on skeletal material, thanks to which it can better understand its genesis.
Syphilis is a disease caused by Treponema pallidum. It is primarily transmitted sexually or vertically during pregnancy. The origin is twofold, namely it comes from America or Europe. Syphilis was first recorded in human skeleton in the 11th century. However, signs of treponemal disease were observed in osteological material from Pleistocene bear. Hence, it is necessary to study syphilis on bone material to better understand the etiology of the above disease and consequently, introduce preventive measures. Literature review was performed, according to PRISMA statement. Examination of syphilis on skeletal material can be performed at the macroscopic and microscopic level. Those methods refer to the visual assessment of skeletal material, namely the identification of characteristic pathological changes caused by syphilis, such as periostitis, which manifests itself as thickenings on the bone surface, and syphilis nodules (gummata), which are defects in the bones. Most often, these changes are found on long bones such as the tibia, femur and skull. Radiological methods may be used, such as X-ray, computed tomography (CT), Micro-CT (ICT) as well as molecular examination. Summarizing, this review is an overview of the latest methodology regarding syphilis research on skeletal material, thanks to which it can better understand its genesis.
Objective: This review aims to describe the macroscopic methods used to detect poliomyelitis in human skeletal remains and to highlight the limitations of current diagnostic frameworks. Materials: The reviewed materials consist of published paleopathological literature and case studies analyzing human skeletal remains for evidence of the disease. Methods: We evaluated existing studies that focus on the macroscopic analysis of secondary skeletal alterations caused by paralysis, such as unilateral limb atrophy, bone shortening, pronounced asymmetry, and compensatory hypertrophy. Results: Current diagnostic frameworks rely almost exclusively on macroscopic markers; notably, none of the reviewed studies utilized molecular or genetic techniques. Consequently, definitively confirmed cases of ancient poliomyelitis remain exceptionally rare. Conclusions: The paleopathological diagnosis of poliomyelitis currently suffers from a substantial methodological gap due to an overreliance on morphological assessments. Transcending these traditional techniques is essential to definitively confirm ancient cases. Significance: Analyzing skeletal evidence provides crucial insights into how this debilitating viral infection afflicted human populations in antiquity. It also underscores the importance of rigorous differential diagnosis to distinguish poliomyelitis from other paralytic etiologies, such as cerebral palsy.
30 October 2026 in Annals of Anatomy - Anatomischer Anzeiger
Background. Dupilumab is a fully human monoclonal antibody targeting the interleukin-4 receptor alpha (IL-4Rα), thereby inhibiting signaling mediated by interleukin-4 (IL-4) and interleukin-13 (IL-13). Since the initial approval for moderate-to-severe atopic dermatitis, its therapeutic indications have expanded substantially and currently include several diseases characterized by type 2 inflammation. Aim. The aim of this narrative review was to summarize the current evidence regarding the mechanism of action, established clinical applications, efficacy, safety, and emerging therapeutic indications of dupilumab. Material and methods. A narrative literature review was performed using PubMed/MEDLINE, Web of Science, supplemented by clinical guidelines and regulatory documents from the U.S. Food and Drug Administration and European regulatory authorities published between 2017 and 2026. Results. Dupilumab has demonstrated clinically relevant efficacy in wide range of dieseases including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis. eosinophilic chronic obstructive pulmonary disease, chronic spontaneous urticaria, bullous pemphigoid, and allergic fungal rhinosinusitis. Inhibition of IL-4Rα results in attenuation of type 2 inflammatory signaling, although the clinical treatment response vary between diseases. Conclusions. Dupilumab has evolved into a broadly applicable biologic targeting a shared immunological pathway across multiple inflammatory diseases. Its expanding indications emphasize the clinical importance of type 2 inflammation as a therapeutic target. Further studies are required to define optimal patient selection, long-term effectiveness, treatment duration, biomarkers of response, and the role of dupilumab in combination or sequencing with other targeted therapies.